SlideShare a Scribd company logo
Cancer and the
Immune System
Dr. B. K. Iyer
Webinar topics ahead
1. Review of immuno-oncology
2. Advances in immuno-oncology
3. Immuno-oncology: understanding function & dysfunction of the immune
system in cancer
4. Melanoma as a model tumour for immuno-oncology
5. Recent immunotherapy advances changing standard of care in
metastatic melanoma
6. Evolving role of immunotherapy in prostate cancer
7. What future opportunities may immuno-oncology provide for improving
the treatment of patients with lung cancer?
8. Emerging immunotherapies for renal cell carcinoma
9. Combination immunotherapy approaches
10. Evolution of end points for cancer immunotherapy trials
11. Can immuno-oncology offer a truly pan-tumour approach to therapy?
A look-ahead
• Immuno-oncology
• Tumors and Metastasis
• Oncogenes and Cancer Induction
• Tumor Antigens
• Tumors and the Immune Response
• Immunotherapy
Immuno-oncology
• Immuno-oncology is a new area of medicine
that focuses on the development and
delivery of therapies that improve the body's
intrinsic potential for generating an effective
immune response against cancer.
• Although immuno-oncology is still in its
infancy, immunotherapy has been yielding
clinical results for some time, and the most
recent agents entering the clinic look even
more promising.
Immuno-oncology
• In April 2010, sipuleucel-T became the first
therapeutic vaccine to be approved by US
FDA for the therapy of prostate cancer.
– Subsequently, in 2011, ipilimumab, a fully human
monoclonal antibody which blocks cytotoxic T-
lymphocyte-associated antigen-4, became the first
agent approved in the EU for the treatment of
adult patients with unresectable or metastatic
melanoma who have received prior therapy that
showed an overall survival benefit in a randomised
phase III trial.
Immuno-oncology
• Hence, many think that immunotherapy
should be considered alongside
1. Surgery,
2. Chemotherapy and
3. Radiotherapy
4. As the 4th
cornerstone of anticancer treatment.
• Influencing the body’s immune system to give
an immune response against cancer is
immuno-oncology's primary focus.
Cancer and the
Immune System
Cancer
“altered self-cells that have escaped normal
growth regulation mechanisms”
neoplasm: tumor
benign vs. malignant
metastasis: spreading of cancerous cells via
blood or lymph to various tissues
Metastasis
22.1
Types of Cancers
carcinoma: endodermal/ectodermal tissue
leukemia/lymphoma: hematopoeitic stem cells
sarcoma: mesodermal connective tissues
What makes cancer
“cancer”?
1. decreased requirements for growth
factors and serum
2. are no longer anchorage dependent
3. grow independently of density
normal cells:
eventually enter Go
confluent monolayer CHECKPOINT FAILURE
contact inhibition
Malignant Transformation
• are like in vitro cancers
• two phases
1.initiation (changes in genome)
2.promotion (proliferation)
Malignant Transformation
• chemical and physical carcinogens
• virally induced transformation
• cultured tumors: good models for study
• cancer cells are basically immortal
Oncogenes…
oncogene: “cancer
gene”; often found in
viral genomes
proto-oncogene:
cellular counterpart
which can be turned
into an oncogene
What can go right?
• induction of cellular
proliferation
• inhibition of cellular
proliferation, a.k.a. tumor-
suppressor genes
• regulation of programmed
cell death
What can go wrong?
• chromosomal translocations
• tandem repeats: HSRs
• mutations in proto-oncogenes
• viral integration
• growth factors and their receptors
Induction of Cancer
Fig. 22.2
Induction of Cancer
To Visualize!
• http://science.education.nih.gov/suppleme
nts/nih1/cancer/activities/activity2_animati
ons.htm
Tumors of the Immune System
• Lymphomas
– Solid tumors w/in lymphoid tissue (bone marrow,
lymph nodes, thymus)
– Hodgkin’s & non-Hodgkin’s
• http://www.lymphomainfo.net/
• Leukemias
– Proliferate as single cells
– Acute or Chronic depending on the progression of
disease
• Acute- appear suddenly and progress rapidly;
arise is less mature cells (ie ALL, AML)
• Chronic- much less aggressive and develop
slowly; mature cells (ie CLL and CML)
Tumor Antigens
• TSTAs
– Tumor Specific Transplantation Antigen
• TATAs
– Tumor Associated Transplantation Antigen
TSTAs
• Unique to tumor cells
• DO NOT occur on normal cells in the body
• Novel proteins created my mutation presented
on class I MHC
• Can either be chemically/physically induced or
virally induced tumor antigens
Chemically/Physically Induced
• Specific Immunologic Response that can
• Protect against later challenge by live cells
• Of the same line but not other tumor-line Cells.
• Methylcholanthrene / UV light
Virally Induced
• Express tumor antigens shared by all tumors induced
by the same virus
• Burkitt’s Lymphoma
– Epstein Barr
• HPV
TATAs
• NOT unique to tumor cells
• DO occur on normal cells in the body
• So where’s the problem?
– Fetal/adult presence
– Concentration of Growth Factors and Growth
Factor Receptors
TATAs cont’d
• Oncofetal Tumor Antigens (AFP & CEA)
– Normally appear in fetus before
immunocompetence
– Later recognized as non-self
• Oncogene Proteins
• Human Melanomas
Virally Induced Tumors
• Virally induced tumors have the same
antigens for each tumor caused by that
virus.
• HPV
Immune Response to Tumors
• Mostly a cell-mediated
response
• NK Cells
– Not MHC restricted
– Fc receptor binds to antibody
coated tumor cell  ADCC
– Chedieak-Higashi syndrome
• Macrophages
– Not MHC restricted
– Elicits ADCC
– TNF-alpha
• Immune Surveillance Theory
So, you have a tumor cell. Now
what?
• You need three things:
1. “See” the cancer
• Ternary complex and costimulation by B7
1. Activate lymphocytes
• Release IL-2, IFN-gamma, and TNF-alpha
1. Cancer cells must be susceptible to killing
• CTL lysis, macrophages, NK cells
Info From:
http://www.brown.edu/Courses/Bio_160/Projects1999/cancer/imevstca.html#Introduction
But if the body has all
these defenses, why do so
many people still have
cancer?
Conniving Cancer
• Bad antibodies?
– Some antibodies do not protect against tumor growth,
but also ENHANCE it.
– Release of immunosuppressive cytokines
• transforming growth factor-beta (TGF-beta), interleukin-10
(IL-10) and vascular endothelial growth factor (VEGF)
• Hide and go Seeking Antigen
– Antigens actually seem to “hide” in the presence of
antibody
– Also, some cancer cells completely shed themselves
of the antigen
Effect TGF-beta IL-10 VEGF
Inhibition of T-cell growth
+ - +
Inhibition of CTL differentiation
+ + +
Inhibition of cytokine production
+ + -
Induction of T-cell anergy
+ - -
Downregulation of cytotoxic potential
+ + -
Inhibition of antigen presentation
+ + -
Shift in the Th1-Th2 balance towards
Th2
+ + -
Downregulation of
adhesion/costimulatory molecules
+ + -
Resistance to CTL-mediated lysis
- + -
Source: Chouaib et al 1997
Conniving Cancer cont.
• Reduction in
Class I MHC
Molecules
And the final blow…
• Lack of Co-
Stimulatory
Signal
Cancer Immunotherapy
• Manipulation of Co-Stimulatory Signal
• Enhancement of APC Activity
• Cytokine Therapy
• Monoclonal Antibodies
• Cancer Vaccines
Manipulation of Co-Stimulatory
Signal
• Tumor immunity can be enhanced by providing the
co-stimulatory signal necessary for activation of CTL
precursors (CTL-Ps)
• Fig. 22.11a
Manipulation of Co-Stimulatory
Signal Cont.
• Basis for Vaccine
– Prevent metastasis after surgical removal or
primary melanoma in human patients
Enhancement of APC Activity
• GM-CSF (Granulocyte-macrophage colony-
stimulating factor)
remember: CSFs are cytokines that induce the
formation of distinct hematopoietic cell lines
• Fig 22.11b
Cytokine Therapy
• Use of recombinant cytokines (singly or in
combination) to augment an immune
response against cancer
– Via isolation and cloning of various cytokine
genes such as:
– IFN-α, β, and γ
– Interleukin 1, 2, 4, 5, and 12
– GM-CSF and Tumor necrosis factor (TNF)
Cytokine Therapy Cont.
I. Interferons
• Most clinical trials involve IFN-α
• Has been shown to induce tumor regression in
hematologic malignancies i.e. leukemias,
lymphomas, melanomas and breast cancer
• All types of IFN increase MHC I expression
• IFN-γ also has also been shown to increase
MHC
II expressionon macrophages and increase
activity of Tc cells, macrophages, and NKs
Cytokine Therapy Cont.
II. Tumor Necrosis Factors
• Kills some tumor cells
• Reduces proliferation of tumor cells without
affecting normal cells
How?
• Hemorrhagic necrosis and regression, inhibits
tumor induced vascularization (angio-genesis)
by damaging vascular endothelium
Cytokine Therapy Cont.
III. In Vitro-Activited LAK & TIL cells
A. Lymphocytes are activated against
tumor
antigens in vitro
• Cultured with x-irradiated tumor cells
in
presence of IL-2
• Generated lymphokine activated
killer
cells (LAKs), which kill tumor cells
without affecting normal cells
In Vitro-Activated LAK and TIF cells Cont.
B. Tumors contain lymphocytes that have
infiltrated tumor and act in anti-tumor
response
• via biopsy, obtained cells and
expanded population in vitro with
• generated tumor-infiltrating lympho-
cytes (TILs)
Monoclonal Antibodies
• Anti-idiotype
• Growth Factors
-HER2
• Immunotoxins
Cancer Vaccines
• Genetic
• Biochemical
HPV
Human Papilloma Virus
• E6
• E7
From Normal to Abnormal:
For more info
• HPV
• Cancer Vaccines
C
C is for
Cancer!

More Related Content

What's hot

Immune response against tumors
Immune response against tumors Immune response against tumors
Immune response against tumors
qussai abbas
 
B-cell development.pptx
B-cell development.pptxB-cell development.pptx
B-cell development.pptx
VaisHali822687
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
naveenagirish
 
Tumor antigen
Tumor antigenTumor antigen
Tumor antigen
Swathi Prabakar
 
B Cell Development
B Cell DevelopmentB Cell Development
B Cell Developmentraj kumar
 
oncogenic viruses ppt.
oncogenic viruses ppt.oncogenic viruses ppt.
oncogenic viruses ppt.
DrRavi Bhushan
 
Cancer and the Immune System
Cancer and the Immune SystemCancer and the Immune System
Cancer and the Immune System
ASHIKH SEETHY
 
Immunosurveillance,
Immunosurveillance,Immunosurveillance,
Immunosurveillance,
farranajwa
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Tumor antigens & classification.pptx
Tumor antigens & classification.pptxTumor antigens & classification.pptx
Tumor antigens & classification.pptx
Kandati Kusuma
 
Antigen Presenting cells(APCs)
Antigen Presenting cells(APCs)Antigen Presenting cells(APCs)
Antigen Presenting cells(APCs)
Azhar's Biology
 
Tcr
TcrTcr
T cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiationT cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiation
Kamaraj College of Engineering & Technology, Virudhunagar
 
Cells and organs of the immune system
Cells and organs of the immune systemCells and organs of the immune system
Cells and organs of the immune systemRashmimali
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
Pashon Hana
 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
madhursejwal
 
T-cell activation
T-cell activationT-cell activation
T-cell activation
Microbiology
 
T CELL RECEPTOR.pptx
T CELL RECEPTOR.pptxT CELL RECEPTOR.pptx
T CELL RECEPTOR.pptx
BinteHawah1
 
Cancer and immune system
Cancer and immune systemCancer and immune system
Cancer and immune system
NidaSajjad2
 

What's hot (20)

Immune response against tumors
Immune response against tumors Immune response against tumors
Immune response against tumors
 
B-cell development.pptx
B-cell development.pptxB-cell development.pptx
B-cell development.pptx
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
 
Tumor antigen
Tumor antigenTumor antigen
Tumor antigen
 
B Cell Development
B Cell DevelopmentB Cell Development
B Cell Development
 
oncogenic viruses ppt.
oncogenic viruses ppt.oncogenic viruses ppt.
oncogenic viruses ppt.
 
Cancer and the Immune System
Cancer and the Immune SystemCancer and the Immune System
Cancer and the Immune System
 
Immunosurveillance,
Immunosurveillance,Immunosurveillance,
Immunosurveillance,
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
 
Tumor antigens & classification.pptx
Tumor antigens & classification.pptxTumor antigens & classification.pptx
Tumor antigens & classification.pptx
 
Antigen Presenting cells(APCs)
Antigen Presenting cells(APCs)Antigen Presenting cells(APCs)
Antigen Presenting cells(APCs)
 
Tcr
TcrTcr
Tcr
 
T cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiationT cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiation
 
Cells and organs of the immune system
Cells and organs of the immune systemCells and organs of the immune system
Cells and organs of the immune system
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
 
T-cell activation
T-cell activationT-cell activation
T-cell activation
 
T CELL RECEPTOR.pptx
T CELL RECEPTOR.pptxT CELL RECEPTOR.pptx
T CELL RECEPTOR.pptx
 
Cancer and immune system
Cancer and immune systemCancer and immune system
Cancer and immune system
 

Viewers also liked

Cancer and the immune system
Cancer and the immune systemCancer and the immune system
Cancer and the immune system
Nick Pellicciotta
 
cell and tissue culturing and cell line
cell and tissue culturing and  cell linecell and tissue culturing and  cell line
cell and tissue culturing and cell line
Microbiology
 
Animal cell lines culturing
Animal cell lines culturingAnimal cell lines culturing
Animal cell lines culturingGirija Anakala
 
immunization
immunizationimmunization
immunization
ssn zhd
 
Climatic drought
Climatic droughtClimatic drought
Climatic drought
Prof. A.Balasubramanian
 
Climate data management
Climate data managementClimate data management
Climate data management
Prof. A.Balasubramanian
 
Weather forecasting
Weather forecastingWeather forecasting
Weather forecasting
Prof. A.Balasubramanian
 
Measurement of meteorological variables
Measurement of meteorological variablesMeasurement of meteorological variables
Measurement of meteorological variables
Prof. A.Balasubramanian
 
Impact of climate on groundwater
Impact of climate on groundwaterImpact of climate on groundwater
Impact of climate on groundwater
Prof. A.Balasubramanian
 
Global Climate Change and its impact on human health
Global Climate Change and its impact on human healthGlobal Climate Change and its impact on human health
Global Climate Change and its impact on human health
Prof. A.Balasubramanian
 
Indicators of climate change
Indicators of climate changeIndicators of climate change
Indicators of climate change
Prof. A.Balasubramanian
 
Maps, cartography and significances
Maps, cartography and significancesMaps, cartography and significances
Maps, cartography and significances
Prof. A.Balasubramanian
 
Climate models
Climate modelsClimate models
Climate models
Prof. A.Balasubramanian
 
Research methodology part 1
Research methodology part 1Research methodology part 1
Research methodology part 1
Prof. A.Balasubramanian
 
Elements of climate and weather
Elements of climate and weatherElements of climate and weather
Elements of climate and weather
Prof. A.Balasubramanian
 
Precipitation -Atmospheric
Precipitation -AtmosphericPrecipitation -Atmospheric
Precipitation -Atmospheric
Prof. A.Balasubramanian
 
Climate observations stations and networks
Climate observations   stations and networksClimate observations   stations and networks
Climate observations stations and networks
Prof. A.Balasubramanian
 
Atmospheric ozone and its depletion
Atmospheric ozone  and its depletionAtmospheric ozone  and its depletion
Atmospheric ozone and its depletion
Prof. A.Balasubramanian
 
Use of toposheets in civil engineering projects
Use of toposheets in civil engineering projectsUse of toposheets in civil engineering projects
Use of toposheets in civil engineering projects
Prof. A.Balasubramanian
 
Recombinant Vaccines
Recombinant VaccinesRecombinant Vaccines
Recombinant Vaccines
Zydus Cadila Healthcare Ltd
 

Viewers also liked (20)

Cancer and the immune system
Cancer and the immune systemCancer and the immune system
Cancer and the immune system
 
cell and tissue culturing and cell line
cell and tissue culturing and  cell linecell and tissue culturing and  cell line
cell and tissue culturing and cell line
 
Animal cell lines culturing
Animal cell lines culturingAnimal cell lines culturing
Animal cell lines culturing
 
immunization
immunizationimmunization
immunization
 
Climatic drought
Climatic droughtClimatic drought
Climatic drought
 
Climate data management
Climate data managementClimate data management
Climate data management
 
Weather forecasting
Weather forecastingWeather forecasting
Weather forecasting
 
Measurement of meteorological variables
Measurement of meteorological variablesMeasurement of meteorological variables
Measurement of meteorological variables
 
Impact of climate on groundwater
Impact of climate on groundwaterImpact of climate on groundwater
Impact of climate on groundwater
 
Global Climate Change and its impact on human health
Global Climate Change and its impact on human healthGlobal Climate Change and its impact on human health
Global Climate Change and its impact on human health
 
Indicators of climate change
Indicators of climate changeIndicators of climate change
Indicators of climate change
 
Maps, cartography and significances
Maps, cartography and significancesMaps, cartography and significances
Maps, cartography and significances
 
Climate models
Climate modelsClimate models
Climate models
 
Research methodology part 1
Research methodology part 1Research methodology part 1
Research methodology part 1
 
Elements of climate and weather
Elements of climate and weatherElements of climate and weather
Elements of climate and weather
 
Precipitation -Atmospheric
Precipitation -AtmosphericPrecipitation -Atmospheric
Precipitation -Atmospheric
 
Climate observations stations and networks
Climate observations   stations and networksClimate observations   stations and networks
Climate observations stations and networks
 
Atmospheric ozone and its depletion
Atmospheric ozone  and its depletionAtmospheric ozone  and its depletion
Atmospheric ozone and its depletion
 
Use of toposheets in civil engineering projects
Use of toposheets in civil engineering projectsUse of toposheets in civil engineering projects
Use of toposheets in civil engineering projects
 
Recombinant Vaccines
Recombinant VaccinesRecombinant Vaccines
Recombinant Vaccines
 

Similar to Cancer and immunology

CANCER3C (1).PPT
CANCER3C (1).PPTCANCER3C (1).PPT
CANCER3C (1).PPT
UmaShanksr
 
Tumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptxTumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptx
Ragavi32
 
Tumor immunology dr. ihsan alsaimary
Tumor immunology  dr. ihsan alsaimaryTumor immunology  dr. ihsan alsaimary
Tumor immunology dr. ihsan alsaimary
dr.Ihsan alsaimary
 
MSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxMSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptx
LilianNkinda
 
11. tumour immunology.pptx
11. tumour immunology.pptx11. tumour immunology.pptx
11. tumour immunology.pptx
nedalalazzwy
 
Immunity to Tumors for medical and health
Immunity to Tumors for medical and healthImmunity to Tumors for medical and health
Immunity to Tumors for medical and health
negeroerena
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer Immunotherapy and Gene Therapy
Cancer Immunotherapy and Gene TherapyCancer Immunotherapy and Gene Therapy
Cancer Immunotherapy and Gene Therapy
Arkaprava Roychaudhury
 
Tumor Immunology
Tumor ImmunologyTumor Immunology
Tumor Immunology
ABED ALRAHMAN DAKKAK
 
Cancer immuno therapy
Cancer immuno therapyCancer immuno therapy
14.tumor immunology and immunotherapy
14.tumor  immunology and immunotherapy14.tumor  immunology and immunotherapy
14.tumor immunology and immunotherapy
Sweta Shrestha
 
Interaction of Radiation with Immunotherapy
Interaction of Radiation with ImmunotherapyInteraction of Radiation with Immunotherapy
Interaction of Radiation with Immunotherapy
Dr. B. Borooah Cancer Institute
 
Immunological aspects of cancer
Immunological aspects of cancerImmunological aspects of cancer
Immunological aspects of cancer
Puppala Santosh
 
ROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPY
ROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPYROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPY
ROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPY
SIVASWAROOP YARASI
 
TUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.pptTUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.ppt
UmaShanksr
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
Dr. Roopam Jain
 
Cancer immunotherapy
Cancer immunotherapy Cancer immunotherapy
Cancer immunotherapy
sivasankar. P
 

Similar to Cancer and immunology (20)

CANCER3C (1).PPT
CANCER3C (1).PPTCANCER3C (1).PPT
CANCER3C (1).PPT
 
Tumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptxTumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptx
 
Tumor immunology dr. ihsan alsaimary
Tumor immunology  dr. ihsan alsaimaryTumor immunology  dr. ihsan alsaimary
Tumor immunology dr. ihsan alsaimary
 
MSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxMSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptx
 
11. tumour immunology.pptx
11. tumour immunology.pptx11. tumour immunology.pptx
11. tumour immunology.pptx
 
Immunity to Tumors for medical and health
Immunity to Tumors for medical and healthImmunity to Tumors for medical and health
Immunity to Tumors for medical and health
 
Immunobiology of cancer
Immunobiology of cancerImmunobiology of cancer
Immunobiology of cancer
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
 
Cancer Immunotherapy and Gene Therapy
Cancer Immunotherapy and Gene TherapyCancer Immunotherapy and Gene Therapy
Cancer Immunotherapy and Gene Therapy
 
Tumor Immunology
Tumor ImmunologyTumor Immunology
Tumor Immunology
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptx
 
Cancer immuno therapy
Cancer immuno therapyCancer immuno therapy
Cancer immuno therapy
 
14.tumor immunology and immunotherapy
14.tumor  immunology and immunotherapy14.tumor  immunology and immunotherapy
14.tumor immunology and immunotherapy
 
Interaction of Radiation with Immunotherapy
Interaction of Radiation with ImmunotherapyInteraction of Radiation with Immunotherapy
Interaction of Radiation with Immunotherapy
 
Immunological aspects of cancer
Immunological aspects of cancerImmunological aspects of cancer
Immunological aspects of cancer
 
Tumourclasss
TumourclasssTumourclasss
Tumourclasss
 
ROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPY
ROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPYROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPY
ROLE OF IMMUNE CELLS IN CANCER AND TARGETING IMMUNE CELLS FOR CANCER THERAPY
 
TUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.pptTUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.ppt
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
 
Cancer immunotherapy
Cancer immunotherapy Cancer immunotherapy
Cancer immunotherapy
 

More from BALASUBRAMANIAM IYER

Project Status Report PowerPoint Template.pptx
Project Status Report PowerPoint Template.pptxProject Status Report PowerPoint Template.pptx
Project Status Report PowerPoint Template.pptx
BALASUBRAMANIAM IYER
 
dyslipidemia6.ppt
dyslipidemia6.pptdyslipidemia6.ppt
dyslipidemia6.ppt
BALASUBRAMANIAM IYER
 
Stem cells in cardiac care
Stem cells in cardiac careStem cells in cardiac care
Stem cells in cardiac care
BALASUBRAMANIAM IYER
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
BALASUBRAMANIAM IYER
 
Infiximab
InfiximabInfiximab
Temisartan + chlorthalidone
Temisartan + chlorthalidoneTemisartan + chlorthalidone
Temisartan + chlorthalidone
BALASUBRAMANIAM IYER
 
Rrt
RrtRrt
1
11
News2
News2News2
NGAL - Acute kidney injury biomarker
NGAL - Acute kidney injury biomarkerNGAL - Acute kidney injury biomarker
NGAL - Acute kidney injury biomarker
BALASUBRAMANIAM IYER
 
Are all arbs the same?
Are all arbs the same?Are all arbs the same?
Are all arbs the same?
BALASUBRAMANIAM IYER
 
Amh test
Amh testAmh test
Karyotyping
KaryotypingKaryotyping
Ca
CaCa
Amh
AmhAmh
Torch
TorchTorch
Triple maternal screen
Triple maternal screenTriple maternal screen
Triple maternal screen
BALASUBRAMANIAM IYER
 
Risk stratification in post cardiac event cases
Risk stratification in post cardiac event casesRisk stratification in post cardiac event cases
Risk stratification in post cardiac event casesBALASUBRAMANIAM IYER
 
Presentation on heart valve devices
Presentation on heart valve devicesPresentation on heart valve devices
Presentation on heart valve devices
BALASUBRAMANIAM IYER
 

More from BALASUBRAMANIAM IYER (20)

Project Status Report PowerPoint Template.pptx
Project Status Report PowerPoint Template.pptxProject Status Report PowerPoint Template.pptx
Project Status Report PowerPoint Template.pptx
 
dyslipidemia6.ppt
dyslipidemia6.pptdyslipidemia6.ppt
dyslipidemia6.ppt
 
Stem cells in cardiac care
Stem cells in cardiac careStem cells in cardiac care
Stem cells in cardiac care
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
 
Infiximab
InfiximabInfiximab
Infiximab
 
Temisartan + chlorthalidone
Temisartan + chlorthalidoneTemisartan + chlorthalidone
Temisartan + chlorthalidone
 
Rrt
RrtRrt
Rrt
 
1
11
1
 
News2
News2News2
News2
 
Cilnidipine
CilnidipineCilnidipine
Cilnidipine
 
NGAL - Acute kidney injury biomarker
NGAL - Acute kidney injury biomarkerNGAL - Acute kidney injury biomarker
NGAL - Acute kidney injury biomarker
 
Are all arbs the same?
Are all arbs the same?Are all arbs the same?
Are all arbs the same?
 
Amh test
Amh testAmh test
Amh test
 
Karyotyping
KaryotypingKaryotyping
Karyotyping
 
Ca
CaCa
Ca
 
Amh
AmhAmh
Amh
 
Torch
TorchTorch
Torch
 
Triple maternal screen
Triple maternal screenTriple maternal screen
Triple maternal screen
 
Risk stratification in post cardiac event cases
Risk stratification in post cardiac event casesRisk stratification in post cardiac event cases
Risk stratification in post cardiac event cases
 
Presentation on heart valve devices
Presentation on heart valve devicesPresentation on heart valve devices
Presentation on heart valve devices
 

Recently uploaded

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 

Recently uploaded (20)

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 

Cancer and immunology

  • 1. Cancer and the Immune System Dr. B. K. Iyer
  • 2. Webinar topics ahead 1. Review of immuno-oncology 2. Advances in immuno-oncology 3. Immuno-oncology: understanding function & dysfunction of the immune system in cancer 4. Melanoma as a model tumour for immuno-oncology 5. Recent immunotherapy advances changing standard of care in metastatic melanoma 6. Evolving role of immunotherapy in prostate cancer 7. What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer? 8. Emerging immunotherapies for renal cell carcinoma 9. Combination immunotherapy approaches 10. Evolution of end points for cancer immunotherapy trials 11. Can immuno-oncology offer a truly pan-tumour approach to therapy?
  • 3. A look-ahead • Immuno-oncology • Tumors and Metastasis • Oncogenes and Cancer Induction • Tumor Antigens • Tumors and the Immune Response • Immunotherapy
  • 4. Immuno-oncology • Immuno-oncology is a new area of medicine that focuses on the development and delivery of therapies that improve the body's intrinsic potential for generating an effective immune response against cancer. • Although immuno-oncology is still in its infancy, immunotherapy has been yielding clinical results for some time, and the most recent agents entering the clinic look even more promising.
  • 5. Immuno-oncology • In April 2010, sipuleucel-T became the first therapeutic vaccine to be approved by US FDA for the therapy of prostate cancer. – Subsequently, in 2011, ipilimumab, a fully human monoclonal antibody which blocks cytotoxic T- lymphocyte-associated antigen-4, became the first agent approved in the EU for the treatment of adult patients with unresectable or metastatic melanoma who have received prior therapy that showed an overall survival benefit in a randomised phase III trial.
  • 6. Immuno-oncology • Hence, many think that immunotherapy should be considered alongside 1. Surgery, 2. Chemotherapy and 3. Radiotherapy 4. As the 4th cornerstone of anticancer treatment. • Influencing the body’s immune system to give an immune response against cancer is immuno-oncology's primary focus.
  • 8. Cancer “altered self-cells that have escaped normal growth regulation mechanisms” neoplasm: tumor benign vs. malignant metastasis: spreading of cancerous cells via blood or lymph to various tissues
  • 10. Types of Cancers carcinoma: endodermal/ectodermal tissue leukemia/lymphoma: hematopoeitic stem cells sarcoma: mesodermal connective tissues
  • 11. What makes cancer “cancer”? 1. decreased requirements for growth factors and serum 2. are no longer anchorage dependent 3. grow independently of density normal cells: eventually enter Go confluent monolayer CHECKPOINT FAILURE contact inhibition
  • 12. Malignant Transformation • are like in vitro cancers • two phases 1.initiation (changes in genome) 2.promotion (proliferation)
  • 13. Malignant Transformation • chemical and physical carcinogens • virally induced transformation • cultured tumors: good models for study • cancer cells are basically immortal
  • 14. Oncogenes… oncogene: “cancer gene”; often found in viral genomes proto-oncogene: cellular counterpart which can be turned into an oncogene
  • 15. What can go right? • induction of cellular proliferation • inhibition of cellular proliferation, a.k.a. tumor- suppressor genes • regulation of programmed cell death
  • 16. What can go wrong? • chromosomal translocations • tandem repeats: HSRs • mutations in proto-oncogenes • viral integration • growth factors and their receptors
  • 20. Tumors of the Immune System • Lymphomas – Solid tumors w/in lymphoid tissue (bone marrow, lymph nodes, thymus) – Hodgkin’s & non-Hodgkin’s • http://www.lymphomainfo.net/ • Leukemias – Proliferate as single cells – Acute or Chronic depending on the progression of disease • Acute- appear suddenly and progress rapidly; arise is less mature cells (ie ALL, AML) • Chronic- much less aggressive and develop slowly; mature cells (ie CLL and CML)
  • 21. Tumor Antigens • TSTAs – Tumor Specific Transplantation Antigen • TATAs – Tumor Associated Transplantation Antigen
  • 22. TSTAs • Unique to tumor cells • DO NOT occur on normal cells in the body • Novel proteins created my mutation presented on class I MHC • Can either be chemically/physically induced or virally induced tumor antigens
  • 23. Chemically/Physically Induced • Specific Immunologic Response that can • Protect against later challenge by live cells • Of the same line but not other tumor-line Cells. • Methylcholanthrene / UV light
  • 24. Virally Induced • Express tumor antigens shared by all tumors induced by the same virus • Burkitt’s Lymphoma – Epstein Barr • HPV
  • 25. TATAs • NOT unique to tumor cells • DO occur on normal cells in the body • So where’s the problem? – Fetal/adult presence – Concentration of Growth Factors and Growth Factor Receptors
  • 26. TATAs cont’d • Oncofetal Tumor Antigens (AFP & CEA) – Normally appear in fetus before immunocompetence – Later recognized as non-self • Oncogene Proteins • Human Melanomas
  • 27. Virally Induced Tumors • Virally induced tumors have the same antigens for each tumor caused by that virus. • HPV
  • 28. Immune Response to Tumors • Mostly a cell-mediated response • NK Cells – Not MHC restricted – Fc receptor binds to antibody coated tumor cell  ADCC – Chedieak-Higashi syndrome • Macrophages – Not MHC restricted – Elicits ADCC – TNF-alpha • Immune Surveillance Theory
  • 29. So, you have a tumor cell. Now what? • You need three things: 1. “See” the cancer • Ternary complex and costimulation by B7 1. Activate lymphocytes • Release IL-2, IFN-gamma, and TNF-alpha 1. Cancer cells must be susceptible to killing • CTL lysis, macrophages, NK cells Info From: http://www.brown.edu/Courses/Bio_160/Projects1999/cancer/imevstca.html#Introduction
  • 30. But if the body has all these defenses, why do so many people still have cancer?
  • 31. Conniving Cancer • Bad antibodies? – Some antibodies do not protect against tumor growth, but also ENHANCE it. – Release of immunosuppressive cytokines • transforming growth factor-beta (TGF-beta), interleukin-10 (IL-10) and vascular endothelial growth factor (VEGF) • Hide and go Seeking Antigen – Antigens actually seem to “hide” in the presence of antibody – Also, some cancer cells completely shed themselves of the antigen
  • 32. Effect TGF-beta IL-10 VEGF Inhibition of T-cell growth + - + Inhibition of CTL differentiation + + + Inhibition of cytokine production + + - Induction of T-cell anergy + - - Downregulation of cytotoxic potential + + - Inhibition of antigen presentation + + - Shift in the Th1-Th2 balance towards Th2 + + - Downregulation of adhesion/costimulatory molecules + + - Resistance to CTL-mediated lysis - + - Source: Chouaib et al 1997
  • 33. Conniving Cancer cont. • Reduction in Class I MHC Molecules
  • 34. And the final blow… • Lack of Co- Stimulatory Signal
  • 35.
  • 36.
  • 37. Cancer Immunotherapy • Manipulation of Co-Stimulatory Signal • Enhancement of APC Activity • Cytokine Therapy • Monoclonal Antibodies • Cancer Vaccines
  • 38. Manipulation of Co-Stimulatory Signal • Tumor immunity can be enhanced by providing the co-stimulatory signal necessary for activation of CTL precursors (CTL-Ps) • Fig. 22.11a
  • 39. Manipulation of Co-Stimulatory Signal Cont. • Basis for Vaccine – Prevent metastasis after surgical removal or primary melanoma in human patients
  • 40. Enhancement of APC Activity • GM-CSF (Granulocyte-macrophage colony- stimulating factor) remember: CSFs are cytokines that induce the formation of distinct hematopoietic cell lines • Fig 22.11b
  • 41. Cytokine Therapy • Use of recombinant cytokines (singly or in combination) to augment an immune response against cancer – Via isolation and cloning of various cytokine genes such as: – IFN-α, β, and γ – Interleukin 1, 2, 4, 5, and 12 – GM-CSF and Tumor necrosis factor (TNF)
  • 42. Cytokine Therapy Cont. I. Interferons • Most clinical trials involve IFN-α • Has been shown to induce tumor regression in hematologic malignancies i.e. leukemias, lymphomas, melanomas and breast cancer • All types of IFN increase MHC I expression • IFN-γ also has also been shown to increase MHC II expressionon macrophages and increase activity of Tc cells, macrophages, and NKs
  • 43. Cytokine Therapy Cont. II. Tumor Necrosis Factors • Kills some tumor cells • Reduces proliferation of tumor cells without affecting normal cells How? • Hemorrhagic necrosis and regression, inhibits tumor induced vascularization (angio-genesis) by damaging vascular endothelium
  • 44. Cytokine Therapy Cont. III. In Vitro-Activited LAK & TIL cells A. Lymphocytes are activated against tumor antigens in vitro • Cultured with x-irradiated tumor cells in presence of IL-2 • Generated lymphokine activated killer cells (LAKs), which kill tumor cells without affecting normal cells
  • 45. In Vitro-Activated LAK and TIF cells Cont. B. Tumors contain lymphocytes that have infiltrated tumor and act in anti-tumor response • via biopsy, obtained cells and expanded population in vitro with • generated tumor-infiltrating lympho- cytes (TILs)
  • 46. Monoclonal Antibodies • Anti-idiotype • Growth Factors -HER2 • Immunotoxins
  • 47.
  • 50. From Normal to Abnormal:
  • 51. For more info • HPV • Cancer Vaccines